Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease



Rating:

Share or cite this content

Citations should be made in the following way:
J. Baker (London, United Kingdom), P. Fenwick (London, United Kingdom), H. Owles (London, United Kingdom), C. Koss (Biberach an der Riß, Germany), K. El-Kasmi (Biberach an der Riß, Germany), P. Barnes (London, United Kingdom), L. Donnelly (London, United Kingdom). IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease. 678

Member's Comments

No comment yet.

Related content which might interest you: Evidence of mast-cell activation in a subset of patients with eosinophilic chronic obstructive pulmonary disease Source: Eur Respir J 2002; 20: 325-331 Year: 2002 IL-17C associates with disease severity during acute exacerbation of chronic obstructive disease and promotes neutrophilic lung inflammation Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations Year: 2019 Suppressed pulmonary expression of leptin in lipopolysaccharide-induced acute and chronic lung inflammation Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS) Year: 2006 Profiling of sputum inflammatory mediators in asthma and chronic obstructive pulmonary disease Source: Annual Congress 2011 - Role of the biomarkers in airway diseases Year: 2011 The role of biomarkers to identify bacterial and eosinophilic airway inflammation in exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring Year: 2010 Association between airway inflammation and systemic inflammation in stable chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010 Systemic inflammation in chronic obstructive pulmonary disease Source: Eur Respir J 2003; 22: 5S-13S Year: 2003 Multiple inflammatory hits and the pathogenesis of severe airway disease Source: Eur Respir J 2006; 27: 884-888 Year: 2006 Interleukin-18 production and pulmonary function in COPD Source: Eur Respir J 2008; 31: 287-297 Year: 2008 The role of inflamatory markers in obstructive pulmonary disease Source: Annual Congress 2012 - Distinguishing phenotypes and dealing with comorbidities in primary care Year: 2012 Pattern of airway inflammation and remodeling in mild chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 The role of inflammation in COPD Source: Research Seminar 2006 - Complexity of patients with multiple chronic diseases Year: 2006 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003 Inflammatory markers in patients with acute exacerbation of chronic obstructive pulmonary disease and role of bacterial infection Source: Annual Congress 2010 - Colonisation and infection in COPD Year: 2010 Airway inflammation during stable and acutely exacerbated chronic obstructive pulmonary disease Source: Eur Respir J 2005; 25: 640-646 Year: 2005 Systemic inflammation: a link between chronic obstructive pulmonary disease and lung cancer? Source: Annual Congress 2009 - Biological and clinical markers in lung cancer Year: 2009 Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 3-5 Year: 2004 Measurements of sputum interleukin-5 in chronic obstructive pulmonary disease patients with eosinophilic airway inflammation Source: Annual Congress 2008 - Phenotyping of asthma and COPD Year: 2008 Periostin as a marker of Th2-related inflammation in patients with different types of chronic obstructive airway disease Source: International Congress 2017 – Biomarker-based asthma control Year: 2017 Exacerbations of chronic obstructive pulmonary disease: when are bacteria important? Source: Eur Respir J 2002; 20: 9S-19S Year: 2002